azomycin has been researched along with Diabetes Mellitus, Type 1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Hu, M; Zheng, C | 1 |
Buse, JB; Cui, Z; Gu, Z; Ligler, FS; Qian, C; Shen, Q; Yu, J; Zhang, Y; Zhu, Y | 1 |
al-Arafaj, A; Hutchison, K; Mannan, RH; McEwan, AJ; Mercer, J; Ryan, EA; Wiebe, LI | 1 |
1 review(s) available for azomycin and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
Topics: Aged; Animals; Antitubercular Agents; Arrhythmias, Cardiac; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diarylquinolines; Drug Interactions; Drug Monitoring; Humans; Hypoglycemic Agents; Middle Aged; Nitroimidazoles; Oxazoles; Polypharmacy; Risk Assessment; Risk Factors; Tuberculosis | 2016 |
2 other study(ies) available for azomycin and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Hypoxia and H
Topics: Animals; Blood Glucose; Cell Hypoxia; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Carriers; Drug Liberation; Glucose; Glucose Oxidase; HeLa Cells; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Insulin; Male; Mice, Inbred C57BL; Nitroimidazoles; Oxidation-Reduction; Peptides; Polyethylene Glycols | 2017 |
An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Gas Monitoring, Transcutaneous; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Foot; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Nitroimidazoles; Peripheral Vascular Diseases; Radionuclide Imaging | 1994 |